

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * epoxygenase P450 pathway (GO:0019373) | 6.70695433 |
| 2 | drug catabolic process (GO:0042737) | 6.41148681 |
| 3 | exogenous drug catabolic process (GO:0042738) | 6.36920691 |
| 4 | cellular glucuronidation (GO:0052695) | 5.94445710 |
| 5 | NADH metabolic process (GO:0006734) | 5.79754113 |
| 6 | urea metabolic process (GO:0019627) | 5.78300851 |
| 7 | uronic acid metabolic process (GO:0006063) | 5.68744426 |
| 8 | glucuronate metabolic process (GO:0019585) | 5.68744426 |
| 9 | drug metabolic process (GO:0017144) | 5.66959414 |
| 10 | nitrogen cycle metabolic process (GO:0071941) | 5.38771592 |
| 11 | omega-hydroxylase P450 pathway (GO:0097267) | 5.38562766 |
| 12 | ethanol oxidation (GO:0006069) | 5.33755778 |
| 13 | urea cycle (GO:0000050) | 5.33409878 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.32880814 |
| 15 | regulation of triglyceride catabolic process (GO:0010896) | 5.17017680 |
| 16 | regulation of protein activation cascade (GO:2000257) | 4.95332845 |
| 17 | hormone catabolic process (GO:0042447) | 4.82145709 |
| 18 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.78763905 |
| 19 | complement activation, alternative pathway (GO:0006957) | 4.71605639 |
| 20 | regulation of bile acid biosynthetic process (GO:0070857) | 4.67068907 |
| 21 | ethanol metabolic process (GO:0006067) | 4.65940299 |
| 22 | angiotensin maturation (GO:0002003) | 4.63700912 |
| 23 | bile acid and bile salt transport (GO:0015721) | 4.62813927 |
| 24 | bile acid metabolic process (GO:0008206) | 4.62661441 |
| 25 | regulation of fibrinolysis (GO:0051917) | 4.62322402 |
| 26 | regulation of complement activation (GO:0030449) | 4.61909218 |
| 27 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.54694816 |
| 28 | L-phenylalanine catabolic process (GO:0006559) | 4.54694816 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 4.50533989 |
| 30 | L-phenylalanine metabolic process (GO:0006558) | 4.44276628 |
| 31 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.44276628 |
| 32 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.36920573 |
| 33 | phenylpropanoid metabolic process (GO:0009698) | 4.31783935 |
| 34 | fructose metabolic process (GO:0006000) | 4.22770711 |
| 35 | flavonoid metabolic process (GO:0009812) | 4.16973120 |
| 36 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.97617357 |
| 37 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.95730276 |
| 38 | protein carboxylation (GO:0018214) | 3.95730276 |
| 39 | bile acid biosynthetic process (GO:0006699) | 3.95066846 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.94705259 |
| 41 | oxidative demethylation (GO:0070989) | 3.91330910 |
| 42 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.90340176 |
| 43 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.90340176 |
| 44 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.86716913 |
| 45 | phospholipid efflux (GO:0033700) | 3.82980546 |
| 46 | regulation of cholesterol esterification (GO:0010872) | 3.82284151 |
| 47 | primary alcohol catabolic process (GO:0034310) | 3.74744046 |
| 48 | fibrinolysis (GO:0042730) | 3.72825254 |
| 49 | negative regulation of sterol transport (GO:0032372) | 3.62847605 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 3.62847605 |
| 51 | intestinal absorption (GO:0050892) | 3.61744480 |
| 52 | blood coagulation, intrinsic pathway (GO:0007597) | 3.61004578 |
| 53 | lipoprotein transport (GO:0042953) | 3.60214092 |
| 54 | alkaloid metabolic process (GO:0009820) | 3.57010995 |
| 55 | arginine metabolic process (GO:0006525) | 3.52665661 |
| 56 | plasma lipoprotein particle remodeling (GO:0034369) | 3.49951911 |
| 57 | protein-lipid complex remodeling (GO:0034368) | 3.49951911 |
| 58 | macromolecular complex remodeling (GO:0034367) | 3.49951911 |
| 59 | amino-acid betaine metabolic process (GO:0006577) | 3.47872323 |
| 60 | oxaloacetate metabolic process (GO:0006107) | 3.47147376 |
| 61 | positive regulation of lipid catabolic process (GO:0050996) | 3.45397477 |
| 62 | acylglycerol homeostasis (GO:0055090) | 3.44864129 |
| 63 | triglyceride homeostasis (GO:0070328) | 3.44864129 |
| 64 | drug transmembrane transport (GO:0006855) | 3.37550193 |
| 65 | negative regulation of blood coagulation (GO:0030195) | 3.36769287 |
| 66 | negative regulation of hemostasis (GO:1900047) | 3.36769287 |
| 67 | heme transport (GO:0015886) | 3.26968161 |
| 68 | high-density lipoprotein particle remodeling (GO:0034375) | 3.25889771 |
| 69 | protein activation cascade (GO:0072376) | 3.23383638 |
| 70 | phosphate ion transmembrane transport (GO:0035435) | 3.18112952 |
| 71 | complement activation, classical pathway (GO:0006958) | 3.17337635 |
| 72 | cholesterol efflux (GO:0033344) | 3.15384448 |
| 73 | drug transport (GO:0015893) | 3.15001837 |
| 74 | complement activation (GO:0006956) | 3.12973032 |
| 75 | proline metabolic process (GO:0006560) | 3.12713958 |
| 76 | plasma lipoprotein particle assembly (GO:0034377) | 3.10854659 |
| 77 | regulation of lipoprotein metabolic process (GO:0050746) | 3.07449623 |
| 78 | * xenobiotic metabolic process (GO:0006805) | 3.06636704 |
| 79 | negative regulation of coagulation (GO:0050819) | 3.06469964 |
| 80 | carnitine metabolic process (GO:0009437) | 3.03467174 |
| 81 | sarcomere organization (GO:0045214) | 3.02407642 |
| 82 | acute-phase response (GO:0006953) | 3.01878483 |
| 83 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.01660682 |
| 84 | glutamate metabolic process (GO:0006536) | 2.99738638 |
| 85 | negative regulation of wound healing (GO:0061045) | 2.99389363 |
| 86 | serine family amino acid catabolic process (GO:0009071) | 2.97434745 |
| 87 | reverse cholesterol transport (GO:0043691) | 2.97167246 |
| 88 | protein-lipid complex assembly (GO:0065005) | 2.96171480 |
| 89 | cholesterol homeostasis (GO:0042632) | 2.91785773 |
| 90 | negative regulation of protein activation cascade (GO:2000258) | 2.91571019 |
| 91 | creatine metabolic process (GO:0006600) | 2.90137493 |
| 92 | monocarboxylic acid catabolic process (GO:0072329) | 2.89233349 |
| 93 | lipoprotein metabolic process (GO:0042157) | 2.87972017 |
| 94 | aromatic amino acid family catabolic process (GO:0009074) | 2.87448798 |
| 95 | primary alcohol metabolic process (GO:0034308) | 2.86450881 |
| 96 | daunorubicin metabolic process (GO:0044597) | 2.86430254 |
| 97 | polyketide metabolic process (GO:0030638) | 2.86430254 |
| 98 | doxorubicin metabolic process (GO:0044598) | 2.86430254 |
| 99 | amino-acid betaine transport (GO:0015838) | 2.86244318 |
| 100 | carnitine transport (GO:0015879) | 2.86244318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.99333467 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.57643321 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.94794037 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.84416918 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.79676754 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.36528630 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.34697440 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.72014374 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.71399000 |
| 10 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.46583544 |
| 11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.06588506 |
| 12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.00606757 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98466745 |
| 14 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.96714938 |
| 15 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.82832309 |
| 16 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.81974159 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.79198384 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.74333642 |
| 19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.74187130 |
| 20 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.71964786 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.66006938 |
| 22 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.61394616 |
| 23 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.60913192 |
| 24 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.56591801 |
| 25 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.56578167 |
| 26 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.50367871 |
| 27 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.46361033 |
| 28 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.45663443 |
| 29 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.42291899 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37186992 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.35627983 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.35352127 |
| 33 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.34905497 |
| 34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34833458 |
| 35 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.31444246 |
| 36 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.30368177 |
| 37 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.30260614 |
| 38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30040169 |
| 39 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29821604 |
| 40 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.29625553 |
| 41 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.29625553 |
| 42 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.28361628 |
| 43 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.24610575 |
| 44 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.22040644 |
| 45 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.20513545 |
| 46 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19185553 |
| 47 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.15562151 |
| 48 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14688846 |
| 49 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14187556 |
| 50 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12076311 |
| 51 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11634641 |
| 52 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.09781459 |
| 53 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.07543968 |
| 54 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07265835 |
| 55 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.06793974 |
| 56 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05459539 |
| 57 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.99855998 |
| 58 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99151902 |
| 59 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97551908 |
| 60 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91402406 |
| 61 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.91340642 |
| 62 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.89829826 |
| 63 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.89043638 |
| 64 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.88827286 |
| 65 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88338716 |
| 66 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.87876670 |
| 67 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.86250361 |
| 68 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.86157133 |
| 69 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.85930592 |
| 70 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84150626 |
| 71 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84094328 |
| 72 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.80924259 |
| 73 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.80751271 |
| 74 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.80314154 |
| 75 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80214822 |
| 76 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.79119945 |
| 77 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.78867043 |
| 78 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.78136074 |
| 79 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.78051793 |
| 80 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.77811950 |
| 81 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.76885649 |
| 82 | CBP_21632823_ChIP-Seq_H3396_Human | 0.75767051 |
| 83 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.74570757 |
| 84 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.74165010 |
| 85 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.73757428 |
| 86 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.73215186 |
| 87 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72777975 |
| 88 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.72008554 |
| 89 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.71099307 |
| 90 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.70986284 |
| 91 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.70583657 |
| 92 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.69561390 |
| 93 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.69415531 |
| 94 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.68865231 |
| 95 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.68518800 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 0.67332198 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 0.67170571 |
| 98 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.66925615 |
| 99 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66888035 |
| 100 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.66587949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.46854441 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.88188159 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.63721899 |
| 4 | MP0005365_abnormal_bile_salt | 4.82057524 |
| 5 | MP0001666_abnormal_nutrient_absorption | 3.93868406 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.86076335 |
| 7 | MP0003868_abnormal_feces_composition | 3.26455087 |
| 8 | MP0003252_abnormal_bile_duct | 2.83402586 |
| 9 | MP0009840_abnormal_foam_cell | 2.69937537 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 2.65415137 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.48164186 |
| 12 | MP0004019_abnormal_vitamin_homeostasis | 2.45942881 |
| 13 | MP0003195_calcinosis | 2.36054026 |
| 14 | MP0000751_myopathy | 2.26685939 |
| 15 | MP0005332_abnormal_amino_acid | 2.24780071 |
| 16 | MP0005670_abnormal_white_adipose | 2.09444423 |
| 17 | MP0002876_abnormal_thyroid_physiology | 2.07660116 |
| 18 | MP0003183_abnormal_peptide_metabolism | 1.91734606 |
| 19 | MP0003806_abnormal_nucleotide_metabolis | 1.87756975 |
| 20 | MP0004084_abnormal_cardiac_muscle | 1.81150918 |
| 21 | MP0009697_abnormal_copulation | 1.80918805 |
| 22 | MP0005330_cardiomyopathy | 1.72837769 |
| 23 | MP0004036_abnormal_muscle_relaxation | 1.65376224 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 1.60101066 |
| 25 | MP0004215_abnormal_myocardial_fiber | 1.52290623 |
| 26 | MP0004147_increased_porphyrin_level | 1.48459591 |
| 27 | MP0009643_abnormal_urine_homeostasis | 1.47693957 |
| 28 | MP0005451_abnormal_body_composition | 1.40157162 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.35990643 |
| 30 | MP0004264_abnormal_extraembryonic_tissu | 1.34808408 |
| 31 | MP0002837_dystrophic_cardiac_calcinosis | 1.34305728 |
| 32 | MP0001764_abnormal_homeostasis | 1.32637505 |
| 33 | MP0000609_abnormal_liver_physiology | 1.31545898 |
| 34 | MP0000749_muscle_degeneration | 1.30616938 |
| 35 | MP0003879_abnormal_hair_cell | 1.29323751 |
| 36 | MP0002972_abnormal_cardiac_muscle | 1.24393584 |
| 37 | MP0003646_muscle_fatigue | 1.23049495 |
| 38 | MP0004145_abnormal_muscle_electrophysio | 1.22340507 |
| 39 | MP0004087_abnormal_muscle_fiber | 1.18174252 |
| 40 | MP0004484_altered_response_of | 1.16722103 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14922568 |
| 42 | MP0005636_abnormal_mineral_homeostasis | 1.13030072 |
| 43 | MP0010234_abnormal_vibrissa_follicle | 1.10465919 |
| 44 | MP0009780_abnormal_chondrocyte_physiolo | 1.09996536 |
| 45 | MP0008775_abnormal_heart_ventricle | 1.09515846 |
| 46 | MP0002971_abnormal_brown_adipose | 1.08042753 |
| 47 | MP0005409_darkened_coat_color | 1.07143962 |
| 48 | MP0006138_congestive_heart_failure | 1.05871564 |
| 49 | MP0002822_catalepsy | 1.03917534 |
| 50 | MP0005319_abnormal_enzyme/_coenzyme | 1.02025046 |
| 51 | MP0004130_abnormal_muscle_cell | 1.01060065 |
| 52 | MP0001544_abnormal_cardiovascular_syste | 1.00564240 |
| 53 | MP0005385_cardiovascular_system_phenoty | 1.00564240 |
| 54 | MP0005620_abnormal_muscle_contractility | 0.99659411 |
| 55 | MP0004043_abnormal_pH_regulation | 0.99489907 |
| 56 | MP0000747_muscle_weakness | 0.98856732 |
| 57 | MP0004270_analgesia | 0.97019939 |
| 58 | MP0010630_abnormal_cardiac_muscle | 0.91977744 |
| 59 | MP0005535_abnormal_body_temperature | 0.90721278 |
| 60 | MP0004510_myositis | 0.87661343 |
| 61 | MP0002132_abnormal_respiratory_system | 0.86070945 |
| 62 | MP0005166_decreased_susceptibility_to | 0.85588853 |
| 63 | MP0010155_abnormal_intestine_physiology | 0.84842973 |
| 64 | MP0002269_muscular_atrophy | 0.83391121 |
| 65 | MP0002106_abnormal_muscle_physiology | 0.82343891 |
| 66 | MP0001765_abnormal_ion_homeostasis | 0.82072984 |
| 67 | MP0009379_abnormal_foot_pigmentation | 0.80651126 |
| 68 | MP0005165_increased_susceptibility_to | 0.79925600 |
| 69 | MP0010368_abnormal_lymphatic_system | 0.78964823 |
| 70 | MP0003137_abnormal_impulse_conducting | 0.78574983 |
| 71 | MP0004085_abnormal_heartbeat | 0.77973956 |
| 72 | MP0009642_abnormal_blood_homeostasis | 0.77731221 |
| 73 | MP0001664_abnormal_digestion | 0.77621947 |
| 74 | MP0006036_abnormal_mitochondrial_physio | 0.74528986 |
| 75 | MP0005666_abnormal_adipose_tissue | 0.73520184 |
| 76 | MP0002078_abnormal_glucose_homeostasis | 0.71357486 |
| 77 | MP0005266_abnormal_metabolism | 0.70201291 |
| 78 | MP0005376_homeostasis/metabolism_phenot | 0.69800930 |
| 79 | MP0003638_abnormal_response/metabolism_ | 0.67525497 |
| 80 | MP0002136_abnormal_kidney_physiology | 0.65983102 |
| 81 | MP0005369_muscle_phenotype | 0.64244450 |
| 82 | MP0005408_hypopigmentation | 0.62981284 |
| 83 | MP0002127_abnormal_cardiovascular_syste | 0.62624578 |
| 84 | MP0000604_amyloidosis | 0.61338142 |
| 85 | MP0000678_abnormal_parathyroid_gland | 0.61174635 |
| 86 | MP0000462_abnormal_digestive_system | 0.60176604 |
| 87 | MP0005187_abnormal_penis_morphology | 0.59547488 |
| 88 | MP0008872_abnormal_physiological_respon | 0.59453567 |
| 89 | MP0002332_abnormal_exercise_endurance | 0.58939197 |
| 90 | MP0005448_abnormal_energy_balance | 0.58771481 |
| 91 | MP0009115_abnormal_fat_cell | 0.58458848 |
| 92 | MP0000598_abnormal_liver_morphology | 0.55339047 |
| 93 | MP0000249_abnormal_blood_vessel | 0.54254074 |
| 94 | MP0005395_other_phenotype | 0.53556151 |
| 95 | MP0005334_abnormal_fat_pad | 0.53431950 |
| 96 | MP0001661_extended_life_span | 0.51685415 |
| 97 | MP0000759_abnormal_skeletal_muscle | 0.51215408 |
| 98 | MP0000538_abnormal_urinary_bladder | 0.50507531 |
| 99 | MP0003656_abnormal_erythrocyte_physiolo | 0.50306542 |
| 100 | MP0002249_abnormal_larynx_morphology | 0.49966888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.88872477 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 6.32548645 |
| 3 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.20241315 |
| 4 | Deep venous thrombosis (HP:0002625) | 6.19441579 |
| 5 | Complement deficiency (HP:0004431) | 5.45243711 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 4.85159734 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 4.37856370 |
| 8 | Abnormality of complement system (HP:0005339) | 4.35730279 |
| 9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.34443748 |
| 10 | Hydroxyprolinuria (HP:0003080) | 3.90863429 |
| 11 | Abnormality of proline metabolism (HP:0010907) | 3.90863429 |
| 12 | Sudden death (HP:0001699) | 3.83544108 |
| 13 | Xanthomatosis (HP:0000991) | 3.83490698 |
| 14 | Bundle branch block (HP:0011710) | 3.77191582 |
| 15 | Hypolipoproteinemia (HP:0010981) | 3.75946705 |
| 16 | Fat malabsorption (HP:0002630) | 3.72712066 |
| 17 | Conjugated hyperbilirubinemia (HP:0002908) | 3.65398931 |
| 18 | Intrahepatic cholestasis (HP:0001406) | 3.61641117 |
| 19 | Glomerulonephritis (HP:0000099) | 3.43849817 |
| 20 | Joint hemorrhage (HP:0005261) | 3.32428817 |
| 21 | Hyperlipoproteinemia (HP:0010980) | 3.31282117 |
| 22 | Hyperammonemia (HP:0001987) | 3.23280068 |
| 23 | Malnutrition (HP:0004395) | 3.22475871 |
| 24 | Ventricular tachycardia (HP:0004756) | 3.15609416 |
| 25 | Hyperglycinuria (HP:0003108) | 3.11156353 |
| 26 | Right ventricular cardiomyopathy (HP:0011663) | 3.11070211 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.09971937 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.09658401 |
| 29 | Heart block (HP:0012722) | 2.99335853 |
| 30 | Exercise-induced myalgia (HP:0003738) | 2.87090911 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.87001937 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 2.87001937 |
| 33 | Hyporeflexia of lower limbs (HP:0002600) | 2.84772300 |
| 34 | Abnormal atrioventricular conduction (HP:0005150) | 2.83662341 |
| 35 | Muscle fiber splitting (HP:0003555) | 2.83405790 |
| 36 | Atrioventricular block (HP:0001678) | 2.82795858 |
| 37 | Abnormality of urine glucose concentration (HP:0011016) | 2.81141671 |
| 38 | Glycosuria (HP:0003076) | 2.81141671 |
| 39 | Asymmetric septal hypertrophy (HP:0001670) | 2.80842856 |
| 40 | Syncope (HP:0001279) | 2.73688756 |
| 41 | Distal lower limb muscle weakness (HP:0009053) | 2.73319883 |
| 42 | Muscle fiber inclusion bodies (HP:0100299) | 2.72271042 |
| 43 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.71656516 |
| 44 | Abnormality of vitamin metabolism (HP:0100508) | 2.66401076 |
| 45 | Steatorrhea (HP:0002570) | 2.66283597 |
| 46 | Nemaline bodies (HP:0003798) | 2.62428648 |
| 47 | Abnormality of nucleobase metabolism (HP:0010932) | 2.61158938 |
| 48 | Abnormality of the calf musculature (HP:0001430) | 2.51559873 |
| 49 | Vascular calcification (HP:0004934) | 2.50517179 |
| 50 | Widely patent fontanelles and sutures (HP:0004492) | 2.49366800 |
| 51 | Metabolic acidosis (HP:0001942) | 2.46664783 |
| 52 | Nephritis (HP:0000123) | 2.46496242 |
| 53 | Rhabdomyolysis (HP:0003201) | 2.45945343 |
| 54 | Abnormality of purine metabolism (HP:0004352) | 2.38930018 |
| 55 | Hemorrhage of the eye (HP:0011885) | 2.38724585 |
| 56 | Acanthocytosis (HP:0001927) | 2.34821571 |
| 57 | Abnormality of the common coagulation pathway (HP:0010990) | 2.33518311 |
| 58 | Generalized aminoaciduria (HP:0002909) | 2.33017072 |
| 59 | Dilated cardiomyopathy (HP:0001644) | 2.32346994 |
| 60 | Potter facies (HP:0002009) | 2.28902284 |
| 61 | Facial shape deformation (HP:0011334) | 2.28902284 |
| 62 | Increased purine levels (HP:0004368) | 2.28343588 |
| 63 | Hyperuricemia (HP:0002149) | 2.28343588 |
| 64 | Atrial fibrillation (HP:0005110) | 2.28076486 |
| 65 | EMG: myopathic abnormalities (HP:0003458) | 2.27606819 |
| 66 | Hyperphosphaturia (HP:0003109) | 2.27554031 |
| 67 | Myoglobinuria (HP:0002913) | 2.26673649 |
| 68 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.26341315 |
| 69 | Ventricular arrhythmia (HP:0004308) | 2.26284902 |
| 70 | Confusion (HP:0001289) | 2.25111961 |
| 71 | Epidermoid cyst (HP:0200040) | 2.24532969 |
| 72 | Calf muscle hypertrophy (HP:0008981) | 2.24433655 |
| 73 | Proximal tubulopathy (HP:0000114) | 2.22174064 |
| 74 | Hypoalphalipoproteinemia (HP:0003233) | 2.22082586 |
| 75 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.20130737 |
| 76 | Type 1 muscle fiber predominance (HP:0003803) | 2.17705684 |
| 77 | Cardiovascular calcification (HP:0011915) | 2.17010434 |
| 78 | Abnormal urine phosphate concentration (HP:0012599) | 2.14330625 |
| 79 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.14063809 |
| 80 | Lipoatrophy (HP:0100578) | 2.11445155 |
| 81 | Ventricular fibrillation (HP:0001663) | 2.11348930 |
| 82 | Osteomalacia (HP:0002749) | 2.10677108 |
| 83 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.09443858 |
| 84 | Abnormality of the intrinsic pathway (HP:0010989) | 2.08410606 |
| 85 | Hyperactive renin-angiotensin system (HP:0000841) | 2.06848638 |
| 86 | Pigmentary retinal degeneration (HP:0001146) | 2.03107363 |
| 87 | Rickets (HP:0002748) | 2.02529853 |
| 88 | Alkalosis (HP:0001948) | 2.02480741 |
| 89 | Gout (HP:0001997) | 2.02146608 |
| 90 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.01498560 |
| 91 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.99922455 |
| 92 | Palpitations (HP:0001962) | 1.99698201 |
| 93 | Skin nodule (HP:0200036) | 1.99210590 |
| 94 | Ileus (HP:0002595) | 1.98868574 |
| 95 | Primary atrial arrhythmia (HP:0001692) | 1.98282871 |
| 96 | Reduced antithrombin III activity (HP:0001976) | 1.96676534 |
| 97 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.89841597 |
| 98 | Subaortic stenosis (HP:0001682) | 1.89841597 |
| 99 | Hypercholesterolemia (HP:0003124) | 1.88483251 |
| 100 | Supraventricular tachycardia (HP:0004755) | 1.88188278 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 4.78533591 |
| 2 | MYLK | 3.59813274 |
| 3 | RIPK1 | 3.49385684 |
| 4 | ACVR1B | 3.47584330 |
| 5 | TTN | 3.06210870 |
| 6 | EPHA2 | 2.67353183 |
| 7 | ERN1 | 2.57560921 |
| 8 | MST1R | 2.54346782 |
| 9 | PIK3CA | 2.34334386 |
| 10 | TRIB3 | 2.23998866 |
| 11 | FGFR4 | 1.99932432 |
| 12 | DMPK | 1.99132321 |
| 13 | PHKG1 | 1.95146901 |
| 14 | PHKG2 | 1.95146901 |
| 15 | MUSK | 1.93591257 |
| 16 | MAPKAPK3 | 1.89038436 |
| 17 | LMTK2 | 1.86651571 |
| 18 | PIK3CG | 1.71512446 |
| 19 | MAP3K12 | 1.71308888 |
| 20 | PRKG2 | 1.65163568 |
| 21 | PDK2 | 1.56555645 |
| 22 | MAPK15 | 1.54349841 |
| 23 | MAP3K2 | 1.41749317 |
| 24 | EPHA4 | 1.41634732 |
| 25 | PRKAA2 | 1.36045358 |
| 26 | CAMK2D | 1.25025908 |
| 27 | CAMK2G | 1.19974017 |
| 28 | MAPK12 | 1.18221506 |
| 29 | MAP3K3 | 1.16393590 |
| 30 | PDPK1 | 1.16151961 |
| 31 | STK24 | 1.11642433 |
| 32 | MET | 1.09976565 |
| 33 | MAP3K7 | 1.09675759 |
| 34 | PRKACG | 1.07874208 |
| 35 | FGFR3 | 1.05807350 |
| 36 | PINK1 | 0.98455008 |
| 37 | TESK1 | 0.97133642 |
| 38 | PTK6 | 0.96788860 |
| 39 | EPHA3 | 0.96469859 |
| 40 | MST4 | 0.91155376 |
| 41 | PKN2 | 0.90754471 |
| 42 | EPHB1 | 0.86557653 |
| 43 | EEF2K | 0.86198214 |
| 44 | STK39 | 0.84968385 |
| 45 | AKT3 | 0.84653114 |
| 46 | CAMK2B | 0.83761490 |
| 47 | ICK | 0.82556880 |
| 48 | PRKD1 | 0.79953063 |
| 49 | PDK1 | 0.78088034 |
| 50 | MAP2K6 | 0.77922209 |
| 51 | PRKAA1 | 0.77359800 |
| 52 | PRPF4B | 0.75829854 |
| 53 | TRPM7 | 0.74524826 |
| 54 | PAK3 | 0.73493521 |
| 55 | KSR2 | 0.71021473 |
| 56 | TBK1 | 0.70756045 |
| 57 | MAP3K10 | 0.70538979 |
| 58 | LIMK1 | 0.69863203 |
| 59 | ROCK1 | 0.67284301 |
| 60 | MAPK11 | 0.64973878 |
| 61 | FER | 0.64831612 |
| 62 | NEK9 | 0.64421666 |
| 63 | CAMK2A | 0.63936876 |
| 64 | RET | 0.63344922 |
| 65 | MAP3K1 | 0.62418257 |
| 66 | MAP2K1 | 0.61913592 |
| 67 | MAP2K2 | 0.60989110 |
| 68 | SGK223 | 0.60866341 |
| 69 | SGK494 | 0.60866341 |
| 70 | PRKACA | 0.60628405 |
| 71 | PRKG1 | 0.59412726 |
| 72 | CDC42BPA | 0.57316062 |
| 73 | PRKCA | 0.56283088 |
| 74 | ERBB2 | 0.55811676 |
| 75 | MAP2K4 | 0.54044360 |
| 76 | PRKCZ | 0.52933146 |
| 77 | SIK1 | 0.52609528 |
| 78 | DYRK1B | 0.51336395 |
| 79 | TYK2 | 0.50227355 |
| 80 | SGK3 | 0.50053630 |
| 81 | AKT2 | 0.49795676 |
| 82 | NEK6 | 0.48692742 |
| 83 | CAMK4 | 0.47408518 |
| 84 | MAPK7 | 0.46576532 |
| 85 | MAPK4 | 0.45489282 |
| 86 | DAPK2 | 0.45293973 |
| 87 | ILK | 0.45092070 |
| 88 | NTRK3 | 0.44062429 |
| 89 | LRRK2 | 0.43908397 |
| 90 | ROCK2 | 0.43436926 |
| 91 | SGK1 | 0.42454201 |
| 92 | STK38 | 0.42335489 |
| 93 | MAP3K5 | 0.41522411 |
| 94 | MARK1 | 0.41053529 |
| 95 | PTK2 | 0.40587962 |
| 96 | SGK2 | 0.38650907 |
| 97 | TAOK1 | 0.38330040 |
| 98 | RPS6KA3 | 0.38302829 |
| 99 | DAPK3 | 0.34992680 |
| 100 | OXSR1 | 0.32446682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31924123 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.31468147 |
| 3 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.15239940 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.97505863 |
| 5 | Retinol metabolism_Homo sapiens_hsa00830 | 2.88417308 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.78677658 |
| 7 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.76928081 |
| 8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.75445455 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.71010513 |
| 10 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.65538397 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.65245599 |
| 12 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.63088533 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.59060062 |
| 14 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.35165555 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.32411431 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.31666185 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.25157483 |
| 18 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.17123285 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 2.10672867 |
| 20 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.01921596 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86547679 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.81884008 |
| 23 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.79405486 |
| 24 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.79000843 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.77031301 |
| 26 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.75112323 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.71131946 |
| 28 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.69825006 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.65683736 |
| 30 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.61203508 |
| 31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.54625444 |
| 32 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.45669309 |
| 33 | * Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.40439231 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.32872462 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.27693145 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.22627480 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.19823344 |
| 38 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.14014005 |
| 39 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.12792932 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.11703168 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.09026411 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06793063 |
| 43 | Mineral absorption_Homo sapiens_hsa04978 | 1.05553235 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.00783030 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00015879 |
| 46 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.97802185 |
| 47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.93426028 |
| 48 | Galactose metabolism_Homo sapiens_hsa00052 | 0.90923534 |
| 49 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90414746 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.86985521 |
| 51 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.81656112 |
| 52 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.74974058 |
| 53 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.74930781 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.73746625 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 0.65828338 |
| 56 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65745363 |
| 57 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.61935666 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.58699578 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57017100 |
| 60 | Prion diseases_Homo sapiens_hsa05020 | 0.55925370 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.54949349 |
| 62 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.54811931 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.52959247 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52817659 |
| 65 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52632508 |
| 66 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.50871420 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49280301 |
| 68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47927044 |
| 69 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46145249 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.46143892 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40758326 |
| 72 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38177640 |
| 73 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.36644124 |
| 74 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.36484735 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31613846 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.29249594 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28571826 |
| 78 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.26187151 |
| 79 | Renin secretion_Homo sapiens_hsa04924 | 0.24843997 |
| 80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24459468 |
| 81 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.24150605 |
| 82 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.23971125 |
| 83 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.20924623 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20162102 |
| 85 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.19911734 |
| 86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.19088933 |
| 87 | Lysine degradation_Homo sapiens_hsa00310 | 0.18131075 |
| 88 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.15952992 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.15348036 |
| 90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.14711975 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.14162308 |
| 92 | Tight junction_Homo sapiens_hsa04530 | 0.13729711 |
| 93 | Insulin secretion_Homo sapiens_hsa04911 | 0.13607623 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.13289665 |
| 95 | Circadian rhythm_Homo sapiens_hsa04710 | 0.09944074 |
| 96 | Other glycan degradation_Homo sapiens_hsa00511 | 0.06988530 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.06206532 |
| 98 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.04887327 |
| 99 | Cocaine addiction_Homo sapiens_hsa05030 | 0.02044819 |
| 100 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.00856754 |

